World Allergy Congress: New Horizon Sessions

New Horizons Session 1: Specific Immunotherapy (SIT): History, Mechanisms and Future - This session is co-sponsored by ALK-Abello & MSD

Gran Cancún (Cancún Center)

Chairpersons: Richard F. Lockey (US) and Dermot Ryan (United Kingdom)

08:00 - 08:10

Welcoming Remarks

08:10 - 08:30

1-1NH: History of SIT

08:30 - 08:50

1-2NH: Mechanisms of Sub-Cutaneous Immunotherapy (SCIT) | Stephen Durham (United Kingdom)

08:50 - 09:10

1-3NH: Mechanisms of Sub-Lingual Immunotherapy (SLIT) | Jean-Pierre Allam (Germany)

09:10 - 09:30

1-4NH: Newer Forms of SIT | Rudolf Valenta (Austria)

New Horizons Session 1: Specific Immunotherapy (SIT): Which Patients for SIT and Anti-IgE? - This session is co-sponsored by ALK-Abello & MSD

Gran Cancún (Cancún Center)

Chairpersons: Richard F. Lockey (US) and Barbara Rogala (Poland)

10:00 - 10:05

Welcoming Remarks

10:05 - 10:30

1-5NH: For SCIT? | Harold Nelson (US)

10:30 - 10:55

1-6NH: For SLIT? | Giorgio Walter Canonica (Italy)

10:55 - 11:20

1-7NH: For Anti-IgE? | Daniel Jackson (US)

11:20 - 11:35

1-8NH: Presentation of the WAO Henning Løwenstein Research Award to Zoulfia Allakhverdi (Canada) and Natalija Novak (Germany)

11:35 - 11:45

Discussion

New Horizons Session 1: Specific Immunotherapy (SIT): Effectiveness of SIT - This session is co-sponsored by ALK-Abello & MSD

Gran Cancún (Cancún Center)

Chairpersons: Eliana Risquez (Venezuela) , Anthony Frew (United Kingdom) and Carlo Tomino (Italy)

13:00 - 13:05

Welcoming Remarks

13:05 - 13:30

1-9NH: SLIT | Giovanni Passalacqua (Italy)

13:30 - 13:55

1-10NH: SIT and Children | Erkka Valovirta (Finland)

13:55 - 14:20

1-11NH: SIT and Asthma | Moises Calderon

14:20 - 14:30

Discussion

New Horizons Session 1: Specific Immunotherapy (SIT): Practical Considerations for SIT - This session is co-sponsored by ALK-Abello & MSD

Gran Cancún (Cancún Center)

Chairpersons: John Kelso (US) and Désirée Larenas Linnemann (Mexico)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:30

1-12NH: When Should SIT be Started and Why? | Lars Jacobsen (Denmark)

15:30 - 15:55

1-13NH: Adverse Effects | Linda Cox (US)

15:55 - 16:20

1-14NH: Cost Effectiveness and Compliance | Cheryl Hankin (US)

16:20 - 16:30

Discussion

New Horizons Session 2: Skin Diseases: Session 1 - This session is co-sponsored by Novartis

Cozumel (Cancún Center)

Chairpersons: María Isabel Rojo Gutiérrez and Marcus Maurer (Germany)

08:00 - 08:05

Welcoming Remarks

08:05 - 08:25

2-1NH: Allergic Skin Disease: Immunologic Consequences of Playing Host to Pathogenic Microbes | Mark Boguniewicz (US)

08:25 - 08:45

2-2NH: Itch: The Primary “Lesion” in Eczema | Johannes Ring (Germany)

08:45 - 09:05

2-3NH: Urticaria and Angioedema | Torsten Zuberbier (Germany)

09:05 - 09:25

2-4NH: Cutaneous Vasculitis | Roger Fox (US)

09:25 - 09:30

Discussion

New Horizons Session 2: Skin Diseases: Session 2 - This session is co-sponsored by Novartis

Cozumel (Cancún Center)

Chairpersons: Allen P. Kaplan (US) and David Fitzhugh (US)

10:00 - 10:05

Welcoming Remarks

10:05 - 10:25

2-5NH: Hereditary Angioedema (HAE) | Bruce Zuraw (US)

10:25 - 10:45

2-6NH: Atopic Dermatitis | Prof. Dr. Peter Schmid-Grendelmeier (Switzerland)

10:45 - 11:05

2-7NH: Contact Dermatitis | Luz Fonacier (US)

11:05 - 11:25

2-8NH: Anti-IgE Therapy in Allergic Skin Diseases | Marcus Maurer (Germany)

11:25 - 11:30

Discussion

New Horizons Session 3: Novel Scientific Approaches in Allergic and Respiratory Diseases: Session 1

Costa Maya (Cancún Center)

Chairpersons: Hae-Sim Park (South Korea) and Peter Creticos (US)

08:00 - 08:05

Welcoming Remarks

08:05 - 08:30

3-1NH: Unique Immunotherapy Approaches | Enrique Fernandez-Caldas (Spain)

08:30 - 08:55

3-2NH: Nanomedicine: Introduction and Overview | James Baker (US)

08:55 - 09:20

3-3NH: Genetics and Genomics Overview: Beyond Genome-Wide Association Studies (GWAS) | Deborah Meyers (US)

09:20 - 09:30

Discussion

New Horizons Session 3: Novel Scientific Approaches in Allergic and Respiratory Diseases: Session 2

Costa Maya (Cancún Center)

Chairpersons: Susan L. Prescott (Australia) and Kari Nadeau (US)

10:00 - 10:05

Welcoming Remarks

10:05 - 10:30

3-4NH: Systems Biology Applications for Allergy and Asthma | Lanny Rosenwasser (US)

10:30 - 10:55

3-5NH: Nanomedicine Applications for Allergy and Vaccines | Shyam Mohapatra (US)

10:55 - 11:20

3-6NH: Genetics and Genomics for Severe Asthma and COPD | Stephen P. Peters (US)

11:20 - 11:30

Discussion

New Horizons Session 4: Drug Allergy: New Insights in Drug Hypersensitivity

Cozumel (Cancún Center)

Chairpersons: Luis Felipe Chiaverini Ensina (Brazil) and Nelson Rosario (Brazil)

13:00 - 13:05

Welcoming Remarks

13:05 - 13:30

4-1NH: Immunogenetics of Severe Drug Hypersensitivity | Daniel Yerly (Switzerland)

13:30 - 13:55

4-2NH: Virus Infections and Drug Hypersensitivity | Barbara Daubner (Switzerland)

13:55 - 14:20

4-3NH: In-Vitro Diagnosis of Drug Allergy: Current Status and Perspectives | Thomas Fleisher (US)

14:20 - 14:30

Discussion

New Horizons Session 4: Drug Allergy: Management of Drug Hypersensitivity

Cozumel (Cancún Center)

Chairpersons: Roger Fox (US) and Barbara Daubner (Switzerland)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:30

4-4NH: Beta-Lactam Allergy Diagnosis and Management | Louis Mendelson (US)

15:30 - 15:55

4-5NH: Intra-Operative Reactions | Pascal Demoly (France)

15:55 - 16:20

4-6NH: Adverse Reactions to Biologics | Thomas Platts-Mills (US)

16:20 - 16:30

Discussion

New Horizons Session 5: Asthma and Co-Morbid Conditions: Session 1

Costa Maya (Cancún Center)

Chairpersons: Alejandra Macías-Weinmann and Mario Zernotti (Argentina)

13:00 - 13:05

Welcoming Remarks

13:05 - 13:30

5-1NH: Overview of Co-Morbid Conditions | Richard F. Lockey (US)

13:30 - 13:55

5-2NH: Polyposis | Marek L Kowalski (Poland)

13:55 - 14:20

5-3NH: Rhinosinusitis | Ruby Pawankar (Japan)

14:20 - 14:30

Discussion

New Horizons Session 5: Asthma and Co-Morbid Conditions: Session 2

Costa Maya (Cancún Center)

Chairpersons: Richard Martin (US) and Marek L Kowalski (Poland)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:30

5-4NH: Vitamin D, Obesity and Asthma | Juan Carlos Celedon (US)

15:30 - 15:55

5-5NH: Gastroesophageal Reflux Disease (GERD) or Laryngopharyngeal Reflux | Dennis Ledford (US)

15:55 - 16:20

5-6NH: Vocal Cord Dysfunction | Mario Zernotti (Argentina)

16:20 - 16:30

Discussion

New Horizons Session 6: Advances in Food Allergy: Session 1

Gran Cancún (Cancún Center)

Chairpersons: Alessandro Fiocchi (Italy) and Ichiro Nomura (Japan)

08:00 - 08:05

Welcoming Remarks

08:05 - 08:30

6-1NH: Allergen Component and Cross Reactivity | Motohiro Ebisawa (Japan)

08:30 - 08:55

6-2NH: Advances in Diagnosis | Hugh Sampson (US)

08:55 - 09:20

6-3NH: Oral Immunotherapy | A. Wesley Burks (US)

09:20 - 09:30

Discussion

New Horizons Session 6: Advances in Food Allergy: Session 2

Gran Cancún (Cancún Center)

Chairpersons: Alessandro Fiocchi (Italy) and Miguel Vinuesa (Argentina)

10:00 - 10:05

Welcoming Remarks

10:05 - 10:30

6-4NH: Hidden Food Allergens | Thomas Holzhauser (Germany)

10:30 - 10:55

6-5NH: Food Allergy and Eosinophilic Esophagitis | Jonathan Spergel (US)

10:55 - 11:20

6-6NH: Non-IgE-Mediated Gastrointestinal Food Reactions | Ichiro Nomura (Japan)

11:20 - 11:30

Discussion

New Horizons Session 7: Asthma in Children: Risk Factors

Cozumel (Cancún Center)

Chairpersons: Kazuo Akiyama (Japan) and Cissy Rachiana Sudjana Prawira

08:00 - 08:05

Welcoming Remarks

08:05 - 08:30

7-1NH: Genetics | Fernando D. Martinez (US)

08:30 - 08:55

7-2NH: Environmental | Dennis Ownby (US)

08:55 - 09:20

7-3NH: Viral | Robert Lemanske, MD (US)

09:20 - 09:30

Discussion

New Horizons Session 7: Asthma in Children: Treatment

Cozumel (Cancún Center)

Chairpersons: José Antonio Ortega Martell (Mexico) and Alvaro Teijeiro (Argentina)

10:00 - 10:05

Welcoming Remarks

10:05 - 10:30

7-4NH: Prevention | Ulrich Wahn (Germany)

10:30 - 10:55

7-5NH: Step Care | Stanley Szefler (US)

10:55 - 11:20

7-6NH: Management of Asthma Exacerbations | Jose A. Castro-Rodriguez (Chile)

11:20 - 11:30

Discussion

New Horizons Session 8: Is Your Patient Immunodeficient (ID)?: Session 1

Costa Maya (Cancún Center)

Chairpersons: Elena Perez (US) and Steven Holland

08:00 - 08:05

Welcoming Remarks

08:05 - 08:30

8-1NH: Primary IDs | Charlotte Cunningham-Rundles (US)

08:30 - 08:55

8-2NH: Common Variable | Mark Ballow (US)

08:55 - 09:20

8-3NH: Approach to the Patient with Recurrent Infections | Zuhair Ballas (US)

09:20 - 09:30

Discussion

New Horizons Session 8: Is Your Patient Immunodeficient (ID)?: Session 2

Costa Maya (Cancún Center)

Chairpersons: Elopy Sibanda (Zimbabwe) and Charlotte Cunningham-Rundles (US)

10:00 - 10:05

Welcoming Remarks

10:05 - 10:30

8-4NH: Immunodeficiency Secondary to Anticytokine Autoantibodies | Steven Holland

10:30 - 10:55

8-5NH: HIV | John Sleasman (US)

10:55 - 11:20

8-6NH: Susceptibility to Infections | Elena Perez (US)

11:20 - 11:30

Discussion

New Horizon Sessions

Sunday, 4 December 2011

08:00 - 16:30

08:00 - 11:30

13:00 - 16:30

Thursday, 8 December 2011

08:00 - 11:30